NervGen Pharma (NervGen Pharma) Total Assets : $23.48 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Total Assets?

NervGen Pharma's Total Assets for the quarter that ended in Mar. 2024 was $23.48 Mil.

During the past 12 months, NervGen Pharma's average Total Assets Growth Rate was 37.40% per year. During the past 3 years, the average Total Assets Growth Rate was 13.60% per year. During the past 5 years, the average Total Assets Growth Rate was 7.90% per year.

During the past 7 years, NervGen Pharma's highest 3-Year average Total Assets Growth Rate was 134.90%. The lowest was -18.80%. And the median was 14.70%.

Total Assets is connected with ROA %. NervGen Pharma's annualized ROA % for the quarter that ended in Mar. 2024 was -41.55%. Total Assets is also linked to Revenue through Asset Turnover. NervGen Pharma's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

NervGen Pharma Total Assets Historical Data

The historical data trend for NervGen Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Total Assets Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

5.14

5.21

13.98

17.58

9.87

NervGen Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															13.96	13.11	12.09	9.87	23.48

NervGen Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

NervGen Pharma's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-1.497	+	11.363
	=	9.87

NervGen Pharma's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	13.908	+	9.573
	=	23.48

NervGen Pharma (OTCPK:NGENF) Total Assets Explanation

Total Assets is connected with ROA %.

NervGen Pharma's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-6.928	/	( (9.866	+	23.482)	/ 2 )
	=	-6.928	/	16.674
	=	-41.55 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

NervGen Pharma's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (9.866	+	23.482)	/ 2 )
=	0	/	16.674
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

NervGen Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

NervGen Pharma (NervGen Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

9UA:Germany NGEN:Canada

Address

2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6

Website

https://www.nervgen.com

NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.

NervGen Pharma (NervGen Pharma) Headlines

From GuruFocus

NervGen Pharma To Webcast At VirtualInvestorConferences.com July 11th

By PRNewswire PRNewswire • 07-09-2019